BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Biotech/Pharma - Earnings
Amgen (AMGN) Announces Webcast Of 2014 Fourth Quarter And Full Year Financial Results 1/23/2015
Catalent, Inc. Announces Second Quarter Fiscal Year 2015 Earnings Conference Webcast 1/23/2015
HEALTHSOUTH Announces Date Of 2014 Fourth Quarter Earnings Conference Call 1/22/2015
Perrigo Company plc To Release Second Quarter Fiscal Year 2015 Results On February 5, 2015 1/22/2015
ImmunoGen, Inc. (IMGN) Announces Conference Call To Discuss Its Second Quarter Fiscal Year 2015 Financial Results 1/22/2015
Affymetrix (Santa Clara, California) (AFFX) To Report Fourth Quarter And Fiscal Year 2014 Operating Results On Wednesday February 4, 2015 1/22/2015
Meridian Bioscience, Inc. (VIVO) Reports First Quarter 2015 Operating Results, Declares Regular Cash Dividend, And Reaffirms Fiscal 2015 Guidance 1/22/2015
Dr. Reddy's Laboratories Ltd. (RDY)'s To Release Q3 FY15 Results On January 29, 2015 1/22/2015
Getinge Announces Date of 2014 Q4 Report and Conference Call 1/21/2015
Seattle Genetics, Inc. (SGEN) To Host Conference Call And Webcast Discussion Of Fourth Quarter And Year 2014 Financial Results On February 10, 2015 1/21/2015
Alexion Pharmaceuticals Inc. (ALXN) To Report Fourth Quarter And Full Year 2014 Results On Thursday, January 29, 2015 1/21/2015
Johnson & Johnson (JNJ) Reports 2014 Fourth-Quarter And Full-Year Results 1/20/2015
Medivir AB (MVRBF): OLYSIO® Sales During The Fourth Quarter 2014 1/20/2015
McKesson Corporation Fiscal 2015 Third Quarter Conference Call Scheduled For February 5, 2015 1/20/2015
Eagle Pharmaceuticals (EGRX) Announces Change In Fiscal Year End 1/20/2015
Quintiles’ Fourth Quarter 2014 Earnings Call Scheduled For Thursday, February 12th 1/19/2015
AbbVie (ABBV) To Host Fourth-Quarter And Full-Year 2014 Earnings Conference Call 1/16/2015
Teva Pharmaceutical Industries Limited (TEVA) To Report Fourth Quarter 2014 Financial Results On February 5, 2015 1/16/2015
PerkinElmer, Inc. (PKI) To Hold Earnings Call On Thursday, January 29, 2015 1/16/2015
Oncologix Tech, Inc.  (OTCBB: OCLG) Announces 1st Quarter Fiscal 2015 Financial Results Showing, New Business, Solid Revenue Growth And Continued Financial Improvements 1/16/2015
Biomerica (BMRA) Announces Second Quarter Financial Results 1/15/2015
Simulations Plus (SLP) Announces Quarterly Cash Dividend Of $0.05 Per Share 1/15/2015
Acasti Pharma Announces Third Quarter Results 1/14/2015
Neptune Technologies & Bioressources Inc. Announces Third Quarter Results 1/14/2015
Dendreon Corporation (DNDN) Announces Strong Commercial Start To 2015 1/14/2015
Fluidigm Corporation Announces Preliminary Fourth Quarter 2014 Revenue And Issues 2015 Revenue Guidance 1/14/2015
J.P. Morgan: Gilead Sciences, Inc. (GILD) President Says 48% of Revenue Comes From Hep C Drugs 1/13/2015
Pharmacyclics, Inc. (PCYC) Announces Preliminary 2014 U.S. Net Product Revenue Results And 2015 U.S. Net Product Revenue Outlook 1/13/2015
Illumina (ILMN) To Announce Fourth Quarter And Fiscal Year 2014 Financial Results On Tuesday, January 27, 2015 1/13/2015
Pacific Biosciences (PACB) Fourth Quarter And Year End 2014 Financial Results Call 1/12/2015
Emergent BioSolutions (EBS) Announces Preliminary 2014 Financial Results And Provides 2015 Financial Outlook 1/12/2015
AMAG Pharmaceuticals, Inc. (AMAG) Provides Business Update And 2015 Financial Guidance 1/12/2015
Adamas Pharmaceuticals (ADMS) Provides Review Of 2014 And Previews Upcoming Business Drivers 1/12/2015
Aegerion Pharmaceuticals, Inc. (AEGR) Reports Preliminary 2014 Net Product Sales, Its Outlook For 2015 And Other Business Updates 1/12/2015
Novadaq Corp. Announces Fourth Quarter 2014 Preliminary Unaudited Revenues And Issues 2015 Revenue Guidance 1/12/2015
BioLife Solutions, Inc. (BLFS.OB) Reports Preliminary Revenue for 2014 1/12/2015
IRIDEX Corporation (IRIX) Announces Preliminary Unaudited Revenues For 2014 Fourth Quarter And Full Year; 2015 Revenue Outlook 1/12/2015
Actavis (ACT) Announces Exceptional Preliminary Fourth Quarter 2014 Performance 1/12/2015
AmerisourceBergen Corporation (ABC) Announces Date And Time For First Quarter Fiscal 2015 Earnings Release 1/12/2015
Affymetrix (Santa Clara, California) (AFFX) Announces Preliminary Fourth Quarter 2014 Revenue Of Approximately $93 Million And The Appointment Of Merilee Raines To The Board Of Directors 1/12/2015
Simulations Plus (SLP) Reports First Quarter FY2015 Financial Results 1/12/2015
Celgene (CELG) Announces 2015 And Long-Term Financial Outlook And Preliminary 2014 Results 1/12/2015
Regeneron (REGN) To Report Fourth Quarter And Full Year 2014 Financial And Operating Results And Host Conference Call And Webcast On February 10, 2015 1/9/2015
Simulations Plus (SLP) Sets Date For 1st Quarter 2015 Earnings Release And Conference Call 1/9/2015
Isis Pharmaceuticals, Inc. (ISIS) Significantly Improves Upon 2014 Financial Guidance 1/8/2015
Abbott Laboratories (ABT) Hosts Conference Call For Fourth-Quarter And Full-Year 2014 Earnings 1/8/2015
Derma Sciences, Inc. (DSCI) Introduces 2015 Financial Guidance And Provides 2014 Preliminary Net Sales 1/8/2015
Pacira Pharmaceuticals, Inc. (PCRX) Reports Estimated Fourth Quarter Total Revenue Of $61.8 Million And Estimated Full-Year Total Revenue Of $197.7 Million 1/8/2015
SciClone Pharmaceuticals, Inc. (SCLN) Provides 2014 Financial Update And 2015 Revenue Guidance 1/8/2015
Reminder: Centene Corporation's 2014 Fourth Quarter And Year-End Financial Results Conference Call 1/7/2015
Mesa Labs (MLAB) Declares Quarterly Dividend 1/7/2015
Neptune Technologies & Bioressources Inc. To Hold Conference Call To Discuss Third Quarter Results 1/6/2015
Mallinckrodt Pharmaceuticals (MNK) To Report First Quarter Fiscal 2015 Results On February 3, 2015 1/6/2015
Cardinal Health To Release Second-Quarter Results For Fiscal Year 2015 On Jan. 29 1/6/2015
Johnson & Johnson (JNJ) Announces Quarterly Dividend For First Quarter 2015 1/5/2015
Merck & Co. (MRK) To Hold Fourth-Quarter And Full-Year 2014 Sales And Earnings Conference Call On February 4 1/5/2015
Anavex Life Sciences Corp. (AVXL.OB) Announces Fiscal 2014 Fourth Quarter And Year-End Financial Results 12/30/2014
Tianyin Pharmaceutical Co, Inc. Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 12/29/2014
CEL-SCI (CVM) Reports Fiscal 2014 Financial Results And Clinical & Corporate Developments 12/29/2014
Microbix Biosystems Inc. (MBXBF) Reports Strong Growth In Revenue And Operating Profit In 2014 12/29/2014
Biogen Idec (BIIB) To Report Fourth Quarter And Year End 2014 Financial Results On January 28, 2015 12/24/2014
CEL-SCI (CVM) Reports Fiscal 2014 Financial Results And Clinical & Corporate Developments 12/24/2014
Ohr Pharmaceutical (OHRP) Reports Fiscal Year 2014 Financial and Business Results 12/23/2014
Apricus Biosciences (APRI) Announces Year-End 2014 Update And 2015 Plans To Advance Its Clinical Pipeline And Further Commercialize Its Erectile Dysfunction Drug Vitaros® 12/22/2014
BASi (BASI) Reports Fourth Quarter And Full Year 2014 Results 12/22/2014
Ohr Pharmaceutical (OHRP) To Announce Fiscal 2014 Financial Results And Host Conference Call On Monday, December 22 12/19/2014
CAPNIA, Inc. Reports Third Quarter 2014 Financial Results 12/19/2014
NeuroDerm Ltd. (NDRM) Announces Third Quarter 2014 Financial Results And Provides A Corporate Update 12/18/2014
BioReference Laboratories, Inc. (BRLI) Announces Quarterly And Yearly Record Revenues, Net Income And Patient Volumes 12/18/2014
Amgen (AMGN) Announces 30 Percent Increase In 2015 First Quarter Dividend 12/18/2014
Neogen Corporation (NEOG) Reports 26% Increase In Net Income 12/18/2014
Baxter International, Inc. (BAX) Fourth Quarter 2014 Financial Results Conference Call 12/18/2014
PAREXEL International (PRXL) Announces Date Of Second Quarter Fiscal Year 2015 Earnings Release And Conference Call 12/17/2014
Bioanalytical Systems, Inc. (BASI) To Release Fourth Quarter Fiscal 2014 Results On Monday December 22, 2014; Conference Call & Webcast Set For 11:00 A.M. EST 12/17/2014
Bristol-Myers Squibb Company (BMY) To Announce Results For Fourth Quarter, Full Year 2014 On January 27 12/17/2014
Tenax Therapeutics (TENX) Announces Second Quarter Fiscal Year 2015 Financial Results 12/17/2014
Eagle Pharmaceuticals (EGRX) Reports Fourth Quarter And Year End 2014 Financial Results 12/17/2014
Coherus Biosciences Reports Third Quarter 2014 Financial And Operating Results 12/16/2014
PDL BioPharma, Inc. (PDLI) Completes Regular Quarterly Dividend Payment 12/16/2014
Helix Biopharma (TSX:HBP) Announces Q1 Fiscal 2015 Results 12/16/2014
Landauer (LDR)Announces Date And Time For Announcement Of Fiscal Fourth Quarter 2014 Results And Conference Call 12/15/2014
Origin Agritech Limited (SEED) To Announce Fiscal 2014 Annual Financial Results On January 8th, 2015 12/15/2014
Xenon Pharmaceuticals Inc. Reports Third Quarter 2014 Financial Results 12/15/2014
Polydex Pharmaceuticals (POLXF) Reports 3rd Quarter Financial Results 12/15/2014
Bioanalytical Systems, Inc. (BASI) To Release Fourth Quarter Fiscal 2014 Results On Wednesday December 17, 2014; Conference Call & Webcast Set For 11:00 A.M. EST 12/15/2014
Champions Oncology, Inc. (CSBR) Reports Results For The Second Quarter Ended October 31, 2014 12/12/2014
Peregrine Pharmaceuticals, Inc. (PPHM) Reports Second Quarter Fiscal Year 2015 Financial Results And Recent Developments 12/12/2014
Abbott Laboratories (ABT) Announces Increase In Quarterly Dividend 12/12/2014
Abzena PLC Release: Interim Results For The Six Months Ended 30 September 2014 12/11/2014
Tenax Therapeutics (TENX) To Provide Corporate Update And Discuss Second Quarter Fiscal Year 2015 Financial Results On December 17, 2014 12/11/2014
BioReference Laboratories, Inc. (BRLI) Announces Earnings Date For Fourth Quarter And Year End For Fiscal Year 2014 12/11/2014
Synergetics USA, Inc. (SURG) Reports First Quarter Of Fiscal Year 2015 Results 12/11/2014
Peregrine Pharmaceuticals, Inc. (PPHM) Declares Quarterly Dividend On Its Series E Convertible Preferred Stock 12/11/2014
Parnell Pharmaceuticals Holdings Announces Change In Fiscal Year-End 12/10/2014
Champions Oncology, Inc. (CSBR) To Announce Second Quarter Financial Results On Friday, December 12 12/10/2014
Dynasil Schedules Fiscal 2014 Financial Results Conference Call 12/10/2014
Enzo Biochem (ENZ) Reports Strong Fiscal First Quarter Results 12/10/2014
Bristol-Myers Squibb Company (BMY) Announces Dividend 12/10/2014
Scancell Holdings Plc Interim Results For The Six Months Ended 31 October 2014 12/10/2014
Patterson Companies Declares Quarterly Dividend 12/10/2014
AVANIR Pharmaceuticals (AVNR) Cancels Previously Scheduled Earnings Call 12/8/2014
OncoSec Medical Inc. Announces First Quarter Results For Fiscal Year End 2015 12/8/2014
Aceto Corporation Board Of Directors Declares Quarterly Cash Dividend 12/5/2014
Eagle Pharmaceuticals (EGRX) To Discuss 2014 Fourth Quarter And Year-End Financial Results On December 17, 2014 12/5/2014
Coherus Biosciences To Host Earnings Conference Call On December 15 12/5/2014
Peregrine Pharmaceuticals, Inc. (PPHM) To Report Second Quarter Fiscal 2015 Financial Results After Market On December 10, 2014 12/5/2014
Consort Medical Interim Results For The Six Months Ended 31 October 2014 12/4/2014
Simulations Plus (SLP) Reports First Quarter FY2015 Preliminary Revenues 12/3/2014
Nevro Corp Reports Third Quarter Financial Results 12/3/2014
Auris Medical AG (EARS) Q3 2014 Earnings Release 12/3/2014
AVANIR Pharmaceuticals (AVNR) Announces Date Of Fiscal 2014 Fourth Quarter Financial Results And Conference Call 12/2/2014
Synergetics USA, Inc. (SURG) Announces Conference Call To Review First Quarter Of Fiscal Year 2015 Results 12/2/2014
GW Pharmaceuticals plc Reports 2014 Q4 And Full Year Financial Results 12/2/2014
Pivotal Therapeutics Inc. Announces Third Quarter Accomplishments And Financial Results 12/1/2014
Auris Medical AG (EARS) To Announce Third Quarter 2014 Financial Results And Host Conference Call On Wednesday, December 3, 2014 12/1/2014
uniQure Announces Results For The Third Quarter Of 2014 12/1/2014
iCo Therapeutics Inc. Announces Third Quarter 2014 Financial Results And Corporate Update 12/1/2014
Antibe Therapeutics Inc. Reports Q2 2015 Interim Financial And Operating Results 12/1/2014
XTL Biopharmaceuticals Ltd. (XTLB) Provides Financial and Operational Update For the Third Quarter of 2014 12/1/2014
Simulations Plus (SLP) Reports FY2014 And Fourth Quarter FY2014 Financial Results 11/26/2014
Arrowhead Research Corporation (ARWR) Reports Fiscal 2014 Year End Financial Results 11/26/2014
China Cord Blood Corporation Reports Financial Results For The Second Quarter And First Half Of Fiscal 2015 11/26/2014
Analogic Corporation (ALOG) Announces Timing For First Quarter 2015 Earnings Conference Call And Webcast 11/26/2014
Pall Corporation (PLL) Reports First Quarter Results 11/25/2014
Proteon Therapeutics, Inc. (PRTO) Announces Third Quarter 2014 Financial Results 11/25/2014
Enanta Pharmaceuticals, Inc. Reports Financial Results For its Fiscal Fourth Quarter And Year Ended September 30, 2014 11/24/2014
GW Pharmaceuticals To Report Q4, Year-End 2014 Financial Results And Host Conference Call On 2 December, 2014 11/24/2014
Bio Blast Pharma Reports Third Quarter Financial Results 11/21/2014
Taxus Cardium (CRXM) Reports On Third Quarter 2014 Results And Corporate Development Activities 11/20/2014
Medivir AB (MVRBF): Interim Report, January – September 2014 11/20/2014
Cellular Biomedicine Group (CBMG) Reports Third Quarter 2014 Financial Results And Provides Business Highlights 11/20/2014
EDAP TMS S.A. (EDAP) Reports Continued Strong Growth In Third Quarter 2014 11/20/2014
Sientra, Inc. (SIEN) Reports Third Quarter 2014 Financial Results 11/20/2014
NeuroVive Pharmaceutical AB: Interim Report 1 Jan. 2014 To 30 Sep. 2014 11/19/2014
Mallinckrodt plc Reports Fiscal 2014 Fourth Quarter And Fiscal 2014 Financial Results 11/19/2014
Marina Biotech, Inc. (MRNA) Announces Third Quarter 2014 Financial Results 11/19/2014
Arrowhead Research Corporation (ARWR) To Report Fiscal 2014 Fourth Quarter And Year End Financial Results 11/19/2014
Cardio3 BioSciences Announces Q3 2014 Business Update 11/18/2014
Agilent Technologies Inc. (A) Reports Fourth-Quarter 2014 Results 11/18/2014
MYOS (MYOS) Reports 2014 Third Quarter Results And Provides Business Update 11/18/2014
Skystar Bio-Pharmaceutical (CGPN) To File Financial Results For Third Quarter Of Fiscal 2014 On Friday, November 14 11/18/2014
Skystar Bio-Pharmaceutical (CGPN) Reports Third Quarter Fiscal Year 2014 Financial Results 11/18/2014
ContraFect Corporation (CFRXU) Announces Third Quarter 2014 Results 11/18/2014
Elite Pharmaceuticals, Inc. (ELI) Reports Financial Results For The Second Quarter Of Fiscal Year 2015 11/18/2014
Palatin Technologies (PTN) Reports First Quarter Fiscal Year 2015 Results; Teleconference And Webcast To Be Held On November 18, 2014 11/18/2014
Omega Protein Corporation (OME) Announces Third Quarter 2014 Financial Results 11/18/2014
China Cord Blood Corporation To Report Second Quarter And First Half Of Fiscal 2015 Financial Results 11/18/2014
Protea Biosciences, Inc. Announces 2014 Third Quarter Financial Results 11/18/2014
Affimed Reports Financial Results For Third Quarter 2014 11/18/2014
Fermentalg Q3 2014 Financial information 11/17/2014
Kite Pharma, Inc. (KITE) Reports Third Quarter 2014 Results 11/17/2014
Tengion Inc. Provides Clinical Update And Reports Third Quarter 2014 Financial Results And Cash Position 11/17/2014
VBI Reports Third Quarter 2014 Financial Results And Provides Update On CMV Vaccine Development 11/17/2014
Arno Therapeutics Reports Third Quarter 2014 Financial And Business Update 11/17/2014
Alcobra (ADHD) Announces Third Quarter Financial Results And Provides Corporate Update 11/17/2014
ConvaTec Announces 2014 Third Quarter Earnings Call 11/17/2014
Inergetics, Inc.: 2014 Third Quarter Earnings Announcement 11/17/2014
Nephros Inc. (NEP) Reports Third Quarter 2014 Financial Results And Announces Launch Of Rights Offering 11/17/2014
Anthera Pharmaceuticals, Inc. (ANTH) Reports 2014 Third Quarter Financial Results And Operational Update 11/17/2014
Sinovac Biotech Ltd. (SVA) Reports Unaudited Third Quarter Financial Results 11/17/2014
ULURU Inc. Reports Third Quarter 2014 Financial Results 11/17/2014
Pressure BioSciences, Inc. (BBII) Reports Third Quarter 2014 Financial Results And Provides Business Update 11/17/2014
ProSensa Holding N.V. (RNA) Announces 3rd Quarter 2014 Financial Results And Recent Corporate Developments 11/17/2014
WuXi PharmaTech Co., Ltd. Reports Record Revenues, CapEx Spending 11/17/2014
Sevion Therapeutics Reports First Quarter 2015 Financial Results 11/17/2014
Corium International, Inc. Reports Fiscal Year-End 2014 Financial Results And Recent Corporate Developments 11/17/2014
Enumeral Biomedical (ENUM) Reports Third Quarter 2014 Financial Results 11/17/2014
Bio-Path Holdings, Inc. (BPTH) Reports Third Quarter 2014 Operational And Financial Results 11/17/2014
Enanta Pharmaceuticals, Inc. To Host Conference Call To Discuss Financial Results For The Fiscal Fourth Quarter And Year Ended September 30, 2014 11/17/2014
Retrophin (RTRX) Reports Third Quarter 2014 Financial Results 11/14/2014
BIOQUAL Presents Financial Results For Fiscal Year 2014 And Declares Dividend 11/14/2014
Nuo Therapeutics Reports Third Quarter 2014 Financial Results 11/14/2014
AxoGen, Inc. (AXGN) Reports 58% Third Quarter Revenue Growth 11/14/2014
Ruthigen Reports Fiscal Second Quarter 2015 Financial Results 11/14/2014
Kindred Bio (KIN) Announces Third Quarter 2014 Financial Results 11/14/2014
Intrexon Corporation Announces Third Quarter 2014 Financial Results 11/14/2014
Celator Pharmaceuticals, Inc. Announces Business Update And Third Quarter 2014 Financial Results 11/14/2014
Pfenex Inc. (PFNX) Reports Third Quarter 2014 Results And Provides Business Update 11/14/2014
Dyadic International, Inc. Reports Q3 2014 Financial Results 11/14/2014
Capstone Therapeutics (CAPS) Will Provide An Operating Update And Announces Third Quarter 2014 Financial Results 11/14/2014
CollabRx, Inc. Reports Second Quarter Fiscal Year 2015 Financial Results 11/14/2014
Cesca Therapeutics Reports First Quarter Fiscal 2015 Results 11/14/2014
Calithera Biosciences, Inc. (CALA) Reports Financial Results For The Fiscal Quarter Ended September 30, 2014 11/14/2014
Palatin Technologies (PTN) To Report First Quarter Fiscal Year 2015 Results 11/14/2014
Catalyst Pharmaceutical Partners, Inc. (CPRX) Announces Third Quarter 2014 Financial Results 11/14/2014
Foamix Pharmaceuticals, Ltd. (FOMX) Reports Financial Results For Third Quarter And Nine Months Ended September 30, 2014 11/14/2014
China Pharma Holdings, Inc. (CPHI.OB) Reports Third Quarter 2014 Financial Results 11/14/2014
Synthetic Biologics, Inc. (SYN) Reports Third Quarter 2014 Financial Results And Operational Highlights 11/14/2014
CASI Pharmaceuticals  (ENMD) Reports Third Quarter 2014 Financial Results 11/14/2014
Flexion Therapeutics (FLXN) Reports Third-Quarter 2014 Financial Results 11/14/2014
Vital Therapies, Inc. (VTI) (VTL) Announces Third Quarter 2014 Financial Results And Provides A Corporate Update 11/14/2014
Agile Therapeutics, Inc. Reports Third Quarter 2014 Financial Results 11/14/2014
Argos Therapeutics, Inc. (ARGS) Reports Third Quarter 2014 Financial Results And Operational Highlights 11/14/2014
Evoke Pharma, Inc. Reports Third Quarter 2014 Results 11/14/2014
Ocera Therapeutics, Inc. (OCRX) Reports Third Quarter 2014 Financial Results 11/14/2014
Nymox Pharmaceutical (NYMX) Reports Third Quarter 2014 Financial Results 11/14/2014
Elite Pharmaceuticals, Inc. (ELI) To Host Quarterly Business Update Call On Wednesday, November 19, 2014 11/14/2014
FEI Company Announces Quarterly Cash Dividend Of $0.25 Per Share 11/14/2014
Cerulean Pharma Inc. (CERU) Reports Third-Quarter 2014 Corporate Highlights And Financial Results 11/14/2014
Emisphere Technologies, Inc. (EMIS) Announces Financial Results For The Third Quarter 2014 11/14/2014